At Symyza Biotech , our Tablet Manufacturing Facility stands as a cornerstone of our pharmaceutical production capabilities. Tablets are among the most widely used dosage forms due to their convenience, precise dosing, stability, and cost-effectiveness. Our state-of-the-art manufacturing unit is designed to produce high-quality tablets that meet stringent regulatory standards and deliver consistent therapeutic outcomes.

With a strong focus on innovation, precision, and quality assurance, Symyza Biotech ensures that every tablet manufactured reflects our commitment to excellence in healthcare.

Overview of Tablet Manufacturing

Tablet manufacturing involves the conversion of active pharmaceutical ingredients (APIs) and excipients into solid dosage forms through a series of carefully controlled processes. These processes ensure uniformity, stability, and efficacy of the final product.

At Symyza Biotech, we manufacture a wide range of tablets, including:

• Analgesic Tablets
• Antibiotic Tablets
• Antipyretic Tablets
• Multivitamin and Nutritional Tablets
• Herbal and Specialty Tablets

Each category is developed and produced with strict adherence to quality and safety standards, ensuring reliable performance and patient satisfaction.

Advanced Manufacturing Infrastructure

Our tablet manufacturing facility is equipped with modern infrastructure and cutting-edge technology, designed to support large-scale production while maintaining precision and consistency. Key features include:

• Dedicated Production Areas: Segregated zones for granulation, compression, coating, and packaging to prevent cross-contamination.
• Cleanroom Environments: Controlled air quality, temperature, and humidity to maintain product integrity.
• Automated Machinery: High-speed tablet compression machines and coating equipment for efficient production.
• Material Handling Systems: Streamlined processes for safe and hygienic movement of raw materials and finished products.

This infrastructure enables us to maintain high productivity while ensuring compliance with GMP standards.

Tablet Manufacturing Process

Symyza Biotech follows a systematic and scientifically validated tablet manufacturing process to ensure quality and consistency:

1. Raw Material Procurement & Testing

All APIs and excipients are sourced from approved vendors and undergo rigorous testing for identity, purity, and potency before use.

2. Granulation

Granulation is the process of converting powders into granules to improve flow properties and compressibility. We employ both:

• Wet Granulation
• Dry Granulation

depending on the nature of the formulation.

3. Blending

Granules are blended with excipients such as binders, disintegrants, and lubricants to ensure uniform distribution of ingredients.

4. Compression

The blended material is compressed into tablets using high-speed tablet presses, ensuring uniform weight, thickness, and hardness.

5. Coating (Optional)

Tablets may be coated for various purposes, including:

• Taste masking
• Controlled or delayed release
• Protection from environmental factors
• Enhanced appearance

6. Quality Control Testing

Tablets undergo rigorous testing for:

• Weight variation
• Hardness and friability
• Disintegration and dissolution
• Content uniformity

7. Packaging

Finished tablets are packaged in blister packs or bottles under controlled conditions to maintain stability and shelf life.

Quality Assurance & Compliance

Quality is the foundation of Symyza Biotech’s tablet manufacturing operations. Our facility operates in strict compliance with:

• WHO-GMP Guidelines
• ISO Certification Standards
• Pharmacopoeial Requirements

Our Quality Assurance (QA) and Quality Control (QC) teams ensure that every batch of tablets meets predefined specifications. This includes:

• Continuous in-process monitoring
• Batch documentation and traceability
• Validation of equipment and processes
• Stability studies for shelf-life determination

This robust quality system ensures that our tablets are safe, effective, and reliable.

Technological Advancements

Symyza Biotech integrates advanced technologies into its tablet manufacturing processes to enhance efficiency and product quality:

• Automated Compression Systems: Ensuring high-speed production with minimal human intervention.
• Advanced Coating Technology: Providing uniform and precise coating for improved functionality.
• Digital Monitoring Systems: Real-time tracking of manufacturing parameters for better control.
• Process Optimization Tools: Enhancing efficiency and reducing waste.

These innovations enable us to maintain consistency while meeting growing market demands.

Product Versatility

Our tablet manufacturing facility is capable of producing a wide variety of tablet types, including:

• Immediate Release Tablets: For rapid therapeutic action.
• Sustained/Controlled Release Tablets: For prolonged drug release and improved patient compliance.
• Chewable Tablets: Designed for easy consumption, especially in pediatric patients.
• Effervescent Tablets: Dissolve in water for convenient intake.
• Film-Coated and Sugar-Coated Tablets: For improved stability and patient acceptability.

This versatility allows us to cater to diverse therapeutic requirements and patient preferences.

Skilled Workforce

Our tablet manufacturing operations are supported by a team of highly skilled professionals, including:

• Formulation scientists
• Production engineers
• Quality assurance and quality control experts
• Regulatory specialists

Regular training programs ensure that our team stays updated with the latest industry practices, technologies, and regulatory requirements.

Safety & Hygiene Standards

Symyza Biotech maintains strict safety and hygiene protocols in its tablet manufacturing facility:

• Use of personal protective equipment (PPE) by all personnel
• Regular cleaning and sanitization of equipment and production areas
• Controlled entry and exit procedures in cleanroom environments
• Strict adherence to contamination control measures

These practices ensure the safety of both our products and our workforce.

Environmental Responsibility

Our tablet manufacturing facility is designed with sustainability in mind. Symyza Biotech implements eco-friendly practices such as:

• Efficient energy utilization
• Waste reduction and recycling
• Safe disposal of pharmaceutical waste
• Environmentally responsible packaging solutions

These initiatives reflect our commitment to sustainable pharmaceutical manufacturing.

Contract Manufacturing & Customization

In addition to our own product range, Symyza Biotech offers contract manufacturing services for tablets:

• Custom formulation development
• Private labeling and branding
• Flexible batch sizes
• End-to-end production support

Our advanced infrastructure and quality systems make us a reliable partner for third-party manufacturing.

Continuous Improvement

Symyza Biotech is committed to continuous improvement in tablet manufacturing. We regularly upgrade our facilities and processes to:

• Incorporate new technologies
• Improve production efficiency
• Enhance product quality
• Meet evolving regulatory requirements

This commitment ensures that our tablet manufacturing capabilities remain at the forefront of the pharmaceutical industry.

Conclusion

Symyza Biotech ’s Tablet Manufacturing Facility exemplifies our dedication to quality, innovation, and patient-centric healthcare. Equipped with advanced technology, robust quality systems, and a skilled workforce, our facility ensures the production of high-quality tablets that meet global standards.

From raw material selection to final packaging, every step of our manufacturing process is carefully controlled to ensure safety, efficacy, and consistency. Our versatile capabilities allow us to produce a wide range of tablet formulations, catering to diverse therapeutic needs.

At Symyza Biotech, tablet manufacturing is more than just a process—it is a commitment to delivering reliable, effective, and high-quality medicines that improve patient health and well-being.